लोड हो रहा है...

Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment Programs

BACKGROUND: Many people who inject drugs in the United States have chronic hepatitis C virus (HCV). On-site treatment in opiate agonist treatment (OAT) programs addresses HCV treatment barriers, but few evidence-based models exist. METHODS: We evaluated the cost-effectiveness of HCV treatment models...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Clin Infect Dis
मुख्य लेखकों: Gutkind, Sarah, Schackman, Bruce R, Morgan, Jake R, Leff, Jared A, Agyemang, Linda, Murphy, Sean M, Akiyama, Matthew J, Norton, Brianna L, Litwin, Alain H, Linas, Benjamin P
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Oxford University Press 2020
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7318779/
https://ncbi.nlm.nih.gov/pubmed/31095683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz384
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!